Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Injectables

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

PANPHARMA Group develops, manufactures, and sells a large range of injectable products (anti-infectives, anaesthetics, …) to hospitals and clinics in France, Germany and through distributors in more than 80 countries all over the world under the PANPHARMA and ROTEXMEDICA brands.

Contact

Ready To Use Liquid & Lyophilized Formulations For IV, IM and SC

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

We offer end to end pharmaceutical formulation development services of ready to use liquid & lyophilized products for IV, IM and SC ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension prod

Contact

Parenteral Preparation

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Injectalia, after some important investments in new technology, in different segregated buildings, mainly manufactures pharmaceutical products under different forms:nPre-filled syringes, Vials, Aseptic filling of solutions and diluents in ampoules.

Contact

Developing Sterile & Pyrogen Free Formulations

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

CARBOGEN AMCIS develops sterile and pyrogen-free parenteral formulations for preclinical and clinical trials. We have over 10 years of experience with injectables, liquids and semi-solid pharmaceutical forms.

Contact

Parenterals

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Aizant's scientists use Quality-By-Design (QbD) tools at all stages of formulation development. Design of experiments (DOE) along with risk assessment strategies allows us to design our experimental plan.

Contact

Sustained Release Parenteral Depots-Long Acting Injectables

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Pharmathen is a research-oriented company aiming at the development of high quality pharmaceutical products both in field of generics and innovative finished formulations. Pharmathen invests more than €20 million annually in Research and Development, developing 10-12 new generic molecules

Contact

Injectable Emulsions

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Etico has highly experienced and skilled research staff to support customers in the area of oncological and non-oncological parenteral product formulation development. Our state of the art laboratory is equipped with isolators to handle potent molecules.

Contact

Parenteral Formulation

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Whether your product is a small molecule or a biotech pharmaceutical (protein, peptide or oligonucleotide), PYRAMID can assist you in the design and execution of pre-formulation and formulation development studies that will help define your final drug product formulation.

Contact

Injectable Suspensions

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

Etico has highly experienced and skilled research staff to support customers in the area of oncological and non-oncological parenteral product formulation development. Our state of the art laboratory is equipped with isolators to handle potent molecules.

Contact

Parenteral Preparation

API & Drug Product Development >> Formulation Development >> Injectable / Parenteral

BIOPHARMA started its activities in 1995 and today is a leading ß -lactams antibiotics manufacturer, with a wide, global and skilled experience in contract manufacturing. The facility, located in Rome’s industrial area of Santa Palomba, is approved by the Italian Authority for the oral and

PharmaCompass >>